Status:
COMPLETED
COG-UK Project Hospital-Onset COVID-19 Infections Study
Lead Sponsor:
University College, London
Collaborating Sponsors:
Public Health England
Conditions:
Covid-19
Nosocomial Infection
Eligibility:
All Genders
Phase:
NA
Brief Summary
Hospitals are recognised to be a major risk for the spread of infections despite the availability of protective measures. Under normal circumstances, staff may acquire and transmit infections, but the...
Detailed Description
Hospitals are recognised to be a major risk for the spread of infections despite the availability of protective measures. Under normal circumstances, staff may acquire and transmit infections, but the...
Eligibility Criteria
Inclusion
- Participants must have confirmed COVID-19 infection and either:
- be a potential hospital-onset COVID-19 infection (HOCI); or
- potential workplace infection from COV-SARS-2 for site-based healthcare workers.
- Participants must have provided nasal swab/pharyngeal swab / combined nasal and pharyngeal swab / nasopharyngeal aspirate or broncho alveolar lavage sample for evaluation in the COG-UK project.
- Participants may be of any age to be included in study For clarity, in the above criterion a potential HOCI is an admitted patient at site with first confirmed test for COVID-19 \>48 hours after admission, where they were not suspected to have COVID-19 at time of admission.
Exclusion
- \- There are no exclusion criteria for COG-UK HOCI
Key Trial Info
Start Date :
October 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 8 2021
Estimated Enrollment :
2170 Patients enrolled
Trial Details
Trial ID
NCT04405934
Start Date
October 15 2020
End Date
October 8 2021
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospitals NHS Foundation Trust
London, United Kingdom